DNPUF
Price:
$4.13
Market Cap:
$223.28B
Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides products for atypical antipsychotic, cultured thymus tissue for pediatric congenital athymia, antiepileptic, and carbapenem antibiotic; and Fabry disease drugs. In additio...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2012-01-17
Stock Exchange
PNK
Ticker
DNPUF
According to Sumitomo Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 0.64. This represents a change of 4.88% compared to the average of 0.61 of the last 4 quarters.
The mean historical Current Ratio of Sumitomo Pharma Co., Ltd. over the last ten years is 1.58. The current 0.64 Current Ratio has changed 3.95% with respect to the historical average. Over the past ten years (40 quarters), DNPUF's Current Ratio was at its highest in in the December 2014 quarter at 3.02. The Current Ratio was at its lowest in in the March 2024 quarter at 0.52.
Average
1.58
Median
1.66
Minimum
0.52
Maximum
2.56
Discovering the peaks and valleys of Sumitomo Pharma Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 125.42%
Maximum Annual Current Ratio = 2.56
Minimum Annual Increase = -61.07%
Minimum Annual Current Ratio = 0.52
Year | Current Ratio | Change |
---|---|---|
2024 | 0.52 | -48.96% |
2023 | 1.02 | -42.90% |
2022 | 1.79 | 8.55% |
2021 | 1.65 | 125.42% |
2020 | 0.73 | -61.07% |
2019 | 1.88 | 13.61% |
2018 | 1.66 | 0.61% |
2017 | 1.65 | -29.75% |
2016 | 2.35 | -8.41% |
2015 | 2.56 | -6.55% |
The current Current Ratio of Sumitomo Pharma Co., Ltd. (DNPUF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.11
5-year avg
1.15
10-year avg
1.58
Sumitomo Pharma Co., Ltd.’s Current Ratio is less than Hypera S.A. (1.81), less than Indivior PLC (0.83), greater than YourWay Cannabis Brands Inc. (0), less than Cumberland Pharmaceuticals Inc. (1.13), less than RAMM Pharma Corp. (3.48), less than Genomma Lab Internacional, S.A.B. de C.V. (1.81), less than Speakeasy Cannabis Club Ltd. (1.04), greater than City View Green Holdings Inc. (0.00), greater than Craftport Cannabis Corp. (0.03), less than Orexo AB (publ) (1.70), less than Indivior PLC (0.83), greater than C21 Investments Inc. (0.47), less than RavenQuest BioMed Inc. (1.14), less than Bhang Inc. (1.22), less than Willow Biosciences Inc. (0.80), less than Alpha Teknova, Inc. (4.73), less than Guardion Health Sciences, Inc. (16.67), less than Lifecore Biomedical, Inc. (1.83), less than Organogenesis Holdings Inc. (3.09), less than Petros Pharmaceuticals, Inc. (0.85),
Company | Current Ratio | Market cap |
---|---|---|
1.81 | $1.85B | |
0.83 | $2.89B | |
0 | $17.82M | |
1.13 | $35.25M | |
3.48 | $15.16M | |
1.81 | $1.27B | |
1.04 | $1.31K | |
0.00 | $730.24K | |
0.03 | $6.28B | |
1.70 | $38.58M | |
0.83 | $3.01B | |
0.47 | $21.37M | |
1.14 | $482.11K | |
1.22 | $23.48K | |
0.80 | $6.06M | |
4.73 | $458.45M | |
16.67 | $4.35M | |
1.83 | $279.89M | |
3.09 | $399.81M | |
0.85 | $2.89M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sumitomo Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sumitomo Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Sumitomo Pharma Co., Ltd.'s Current Ratio?
How is the Current Ratio calculated for Sumitomo Pharma Co., Ltd. (DNPUF)?
What is the highest Current Ratio for Sumitomo Pharma Co., Ltd. (DNPUF)?
What is the 3-year average Current Ratio for Sumitomo Pharma Co., Ltd. (DNPUF)?
What is the 5-year average Current Ratio for Sumitomo Pharma Co., Ltd. (DNPUF)?
How does the current Current Ratio for Sumitomo Pharma Co., Ltd. (DNPUF) compare to its historical average?